AS ONE (7476) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Jan, 2026Executive summary
Net sales for the nine months ended December 31, 2025, rose 5.1% year-over-year to ¥79,204 million, with operating profit up 12.4% to ¥9,435 million and profit attributable to owners of parent up 12.4% to ¥6,715 million.
Gross profit margin improved to 30.6% (up 0.3 points), driven by enhanced profitability in long-tail and imported products.
Comprehensive income surged 78.3% year-over-year to ¥7,316 million.
Financial highlights
Operating profit margin increased to 11.9% from 11.1% year-over-year.
SG&A expenses rose 2.6% to ¥14,810 million, but the SG&A ratio improved by 0.5 points to 18.7%.
Basic earnings per share for the period were ¥93.78, up from ¥83.38 year-over-year.
Equity-to-asset ratio improved to 68.4% from 66.5% at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast is ¥108,900 million (up 5.0% year-over-year), with operating profit projected at ¥12,510 million (up 7.9%) and profit attributable to owners of parent at ¥8,940 million (up 8.6%).
Annual dividend forecast raised to ¥63.00 per share.
Latest events from AS ONE
- Record profit growth and margin gains offset medical sector weakness; profit outlook raised.7476
Q2 202631 Oct 2025 - Strong profit and sales growth driven by scientific and industrial demand; outlook maintained.7476
Q1 202631 Jul 2025 - Record sales and profit growth driven by e-commerce and product expansion.7476
Q2 202513 Jun 2025 - Record sales and profit growth, led by e-commerce, offset by lower gross margin.7476
Q1 202513 Jun 2025 - Record sales, profit, and dividend growth with strong EC momentum and positive outlook.7476
Q4 20256 Jun 2025 - Net sales and profits rose over 10% year-on-year, with robust e-commerce and digital growth.7476
Q3 20255 Jun 2025